Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Lymphoma, Follicular × Radiotherapy × Clear all

Phase

Phase 2 38 Phase 3 15 Phase 1 9 Phase 1/2 6 Phase NA 5 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia 5 Esophageal Squamous Cell Carcinoma 5 Esophageal Neoplasms 5 Rectal Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Oropharyngeal Neoplasms 2 Oligodendroglioma 2 Nasopharyngeal Carcinoma 2 Myelodysplastic Syndromes 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, T-Cell 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Acute 2 Leukemia, Myeloid, Accelerated Phase 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Astrocytoma 2 Anemia, Refractory, with Excess of Blasts 2 Adenocarcinoma Of Esophagus 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Sezary Syndrome 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1

Interventions

Rituximab 3 fludarabine phosphate 2 Etoposide 2 Cyclophosphamide 2 umbralisib 1 ublituximab 1 remdesivir 1 fludarabine 1 epratuzumab 1 aldesleukin 1 Whole-Body Irradiation 1 UE2343 1 Transplantation, Homologous 1 Transplantation, Autologous 1 Thiotepa 1 Therapeutics 1 Tacrolimus 1 Standard of Care 1 Radiotherapy 1 Radioimmunodetection 1 Methotrexate 1 Melphalan 1 Hydrochlorothiazide 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Drug Therapy 1 Dosage Forms 1 Carmustine 1 Carboplatin 1 COVID-19 Serotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00096460 2023-01-05

BMT CTN 0202

Medical College of Wisconsin

Phase 2/3 Terminated

30 enrolled 5 charts

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡